Insights

GHO Capital to Acquire FotoFinder Systems

Choate represented GHO Capital, the European specialist investor in global healthcare, as U.S. counsel in its agreement to acquire a majority holding in FotoFinder Systems from current majority owner EMZ Partners.

Choate Lawyers and Practice Groups Recognized by Chambers USA 2025

The 2025 edition of Chambers USA Guide to America’s Leading Lawyers for Business recognized 34 Choate attorneys as leading counsel in their respective fields, with eight receiving Band 1 rankings.

Sara Frank to Moderate at the Suffolk Law Journal of Health & Biomedical Law Symposium

Sara Frank will moderate at the Suffolk Law Journal of Health & Biomedical Law Symposium, "Unveiling Modern Health Law Trends & Challenges" on February 27, 2025 at 3:00 p.m.

FDA Issues Draft Guidance Regarding AI Models Used in Support of Regulatory Decisions Highlighting Changing Risks and Opportunities for IP Strategy

In early January 2025, FDA issued draft guidance titled, Considerations for the Use of Artificial Intelligence to Support Regulatory Decision Making for Drug and Biological Products (“Draft Guidance”), regarding the use of artificial intelligence (AI) to support FDA decision-making in the drug product lifecycle.

31 Choate Attorneys Named to Massachusetts Supreme Judicial Court 2023 Pro Bono Honor Roll

31 Choate attorneys have been recognized by the Massachusetts Supreme Judicial Court’s Pro Bono Honor Roll for distinguished service by providing volunteer legal services for those most in need.

Sara Frank to Moderate at Pharmaceutical and Medical Device Ethics and Compliance Congress

Sara Frank will moderate the panel "Qui Tam Declinations—Analysis and Trends When DOJ Declines to Intervene" at the 25th Annual Pharmaceutical and Medical Device Ethics and Compliance Congress on Tuesday, October 29th at 9:00 a.m.

Sara Frank to Moderate Training Programs Panel at Compliance Congress for Specialty Products

Sara Frank will moderate the panel, "Developing High Impact Training Programs as Culture and Working Practices Evolve in Specialty Pharmaceutical Firms," at the annual Compliance Congress for Specialty Products on Wednesday, September 25, 2024 at 4:00 p.m.

BIOSECURE Act - Looking Ahead

In this episode of Choate’s Life Sciences Insights podcast series, Adam Bookbinder and Sara Frank discuss the current status of the BIOSECURE Act in Congress, and the related implications and practical takeaways life science companies may want to consider at this time.

Choate Lawyers and Practice Groups Recognized by Chambers 2024

The 2024 edition of Chambers USA Guide to America’s Leading Lawyers for Business recognized 34 Choate attorneys as leading counsel in their respective fields, with seven receiving Band 1 rankings.